2-Chloro-N-(6-methyl-4,5,6,7-tetrahydro-benzothiazol-2-yl)-acetamide, 95.0%, 1g

2-Amino-5-methyl-4,5,6,7-tetrahydrothiazolo[4,5-c]pyridine, 95.0%, 250mg

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(2,3-bis(palmitoyloxy)propyl)-L-cysteine, 97%, 10g

(2-Aminopyridin-4-yl)dimethylphosphine oxide, 98%, 250mg

methyl 2-oxo-2,3-dihydro-1,3-benzoxazole-6-carboxylate, 95+%, 5g

3,5-Diiodo-4-methylbenzaldehyde, 97.0%, 250mg

Sodium selenate, min. 99%, pa, 50 g, plastic packaging.

1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)-propane-1,3-diol, 95.0%, 100mg

1-((R)-3-Hydroxy-pyrrolidin-1-yl)-ethanone, 95.0%, 5g

Methanesulphonic acid, 99.0%, 25g

Microliter syringe MICROLITER® series 700 Point type 3, 10 µl, 701 NR, 1 piece

7-Oxa-2-azaspiro[3.5]nonane, 95.0%, 250mg

3-(Trifluoromethyl)cyclohex-2-en-1-one, 98%, 500mg